Detalhe da pesquisa
1.
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 400(10358): 1103-1116, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099926
2.
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.
J Immunol
; 187(2): 708-17, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670315
3.
Eating Healthy: Understanding Added Sugar through Proportional Reasoning.
Int J Environ Res Public Health
; 18(23)2021 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886547